Back to top

Image: Bigstock

Precigen (PGEN) Looks Good: Stock Adds 7.1% in Session

Read MoreHide Full Article

Precigen, Inc. (PGEN - Free Report) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $3.50–$5.69 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Precigen currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Precigen, Inc. Price

A better-ranked stock in the Medical - Biomedical and Genetics industry is Castle Biosciences, Inc. (CSTL - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Precigen, Inc. (PGEN) - free report >>

Castle Biosciences, Inc. (CSTL) - free report >>